Oaktree Acquisition Corp. III Life Sciences - Class A ordinary shares, par value $0.0001 per share (OACC)

Historical Holders from Q4 2024 to Q3 2025

Type / Class
Equity / Class A ordinary shares, par value $0.0001 per share
Symbol
OACC on Nasdaq
Shares outstanding
19,597,244
Price per share
$10.58
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
16,380,578
Total reported value
$171,925,843
% of total 13F portfolios
0%
Share change
-100,951
Value change
-$981,779
Number of holders
47
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Oaktree Acquisition Corp. III Life Sciences - Class A ordinary shares, par value $0.0001 per share (OACC) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Oaktree Acquisition Holdings III LS, LLC 22% $56,270,473 5,500,535 Oaktree Acquisition Holdings III LS, LLC 31 Dec 2024
AQR CAPITAL MANAGEMENT LLC 7.3% $14,841,172 1,450,750 AQR Capital Management, LLC 31 Mar 2025
BARCLAYS PLC 7.2% $13,290,049 1,299,125 Barclays PLC 31 Mar 2025
GOLDMAN SACHS GROUP INC 4.1% -37% $8,396,439 -$5,580,457 803,487 -40% THE GOLDMAN SACHS GROUP, INC. 30 Jun 2025
HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND 3.5% -57% $7,161,000 -$10,230,000 700,000 -59% Healthcare of Ontario Pension Plan Trust Fund 31 Mar 2025
MILLENNIUM MANAGEMENT LLC 1.4% $2,901,850 277,689 Millennium Management LLC 30 Jun 2025
As of 30 Sep 2025, Oaktree Acquisition Corp. III Life Sciences - Class A ordinary shares, par value $0.0001 per share (OACC) has 47 institutional shareholders filing 13F forms. They hold 16,380,578 shares. of 19,597,244 outstanding shares (84%) .

Top 25 institutional shareholders own 72% of the company.

Filer Ownership Nb Shares Share Change % Portfolio % Holdings Value
AQR Arbitrage LLC 7.2% 1,412,750 -2.6% 0.38% $14,791,493
TORONTO DOMINION BANK 4.8% 934,000 +24% 0.02% $9,816,340
D. E. Shaw & Co., Inc. 4.4% 861,625 0% 0.01% $9,021,214
Empyrean Capital Partners, LP 3.8% 750,000 0.32% $7,882,500
Boussard & Gavaudan Investment Management LLP 3.8% 750,000 0% 3.1% $7,890,000
Driehaus Capital Management LLC 3.6% 712,924 -5.8% 0.05% $7,464,314
HighTower Advisors, LLC 3.4% 657,628 -4.2% 0.01% $6,911,670
Decagon Asset Management LLP 3.3% 644,321 +4.3% 3.6% $6,771,814
Linden Advisors LP 3.1% 600,000 0% 0.04% $6,282,000
GOLDMAN SACHS GROUP INC 2.7% 529,535 0% 0% $5,565,413
MOORE CAPITAL MANAGEMENT, LP 2.7% 525,000 0% 0.11% $5,517,750
LMR Partners LLP 2.6% 510,900 0% 0.07% $5,369,559
Sculptor Capital LP 2.6% 500,000 0% 0.07% $5,255,000
Alberta Investment Management Corp 2.6% 500,000 0% 0.05% $5,235,000
HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND 2.3% 450,000 0% 0.01% $4,711,500
Ghisallo Capital Management LLC 2.3% 450,000 0% 0.15% $4,711,500
TWO SIGMA INVESTMENTS, LP 2.2% 437,500 0% 0.01% $4,598,125
Hudson Bay Capital Management LP 2% 400,000 0% 0.03% $4,188,000
Periscope Capital Inc. 2% 400,000 0% 1% $4,204,000
GRITSTONE ASSET MANAGEMENT LLC 2% 394,908 -0.93% 4.3% $4,150,483
GLAZER CAPITAL, LLC 1.9% 365,100 0% 0.13% $3,837,000
Shaolin Capital Management LLC 1.8% 350,866 +80% 0.18% $3,687,602
TENOR CAPITAL MANAGEMENT Co., L.P. 1.5% 300,000 0% 0.04% $3,153,000
Governors Lane LP 1.5% 300,000 0% 0.44% $3,153,000
COMMONWEALTH OF PENNSYLVANIA PUBLIC SCHOOL EMPLS RETRMT SYS 1.4% 275,170 0% 0.01% $2,892,037

Institutional Holders of Oaktree Acquisition Corp. III Life Sciences - Class A ordinary shares, par value $0.0001 per share (OACC) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2025 Q3 16,380,578 $171,925,843 -$981,779 $10.51 47
2025 Q2 16,481,529 $172,447,168 +$16,137,778 $10.45 47
2025 Q1 14,996,124 $153,193,850 +$61,471,497 $10.23 39
2024 Q4 8,990,036 $89,803,971 +$78,749,070 $9.96 20